This week’s News Flash highlights five clinically useful publications appearing in the August literature. The emphasis is on treatment persistence, body composition, oral obesity medications, and practical decisions about treatment goals. 1. Why Do Patients Stop GLP-1 Medications? A New National Survey Adds Real-World Detail Evidence status: Peer-reviewed national survey A newly published U.S. survey
This week’s update highlights four clinically relevant studies that were not central topics in the prior Belite report. The findings involve early treatment response, medication persistence, reduced-frequency maintenance dosing, bone health, and cardiovascular outcomes. Several are observational or exploratory and should not be interpreted as definitive practice-changing evidence. Rapid Early Weight Loss Did Not Appear
